A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile idiopathic arthritis for chronic uveitis risk, according to data published in Arthritis & Rheumatology.
“The reason why we started this study is that patients with JIA are nowadays still classified as having a ‘high,’ ‘moderate’ or ‘low’ risk for developing chronic uveitis according to current screening guidelines,” Joeri W. van Straalen, MSc, of the department of pediatric immunology and rheumatology at Wilhelmina Children's